Articles
10 June 2009
Vol. 2 No. 13: It’s time to take care of T-Cell Lymphomas Bologna, Italy, 22-24 October 2006

Forodesine – Preclinical Studies

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
179
Views
568
Downloads

Authors

Chemically forodesine is [(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol]. The agent is also known as immucillin hypoxanthine (immucillin H) or BCX-1777. This is a potent inhibitor of the enzyme purine nucleoside phosphorylase (PNP).

Altmetrics

Downloads

Citations

Supporting Agencies

How to Cite



Forodesine – Preclinical Studies. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 2(13). https://doi.org/10.4081/hmr.v2i13.484